GlassScriptPhysician profile
Donna L Kelly
NPI 1730566647
$1,938.73
in general payments reported to CMS, 2019-2025
16 companies · $771 in 2025
The $771 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $120 · 2022: $32.93 · 2023: $419 · 2024: $596 · 2025: $771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,765 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,765.35 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $709.56 | 2023-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $262.86 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Lucid Diagnostics INC. | $123.77 | 2023-2024 | |
| Amgen INC. | $119.94 | 2021-2025 | Otezla, Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $112.99 | 2024-2025 | |
| Lilly USA, LLC | $108.77 | 2024-2025 | Jardiance, Mounjaro, Zepbound |
| Verona Pharma, INC. | $106.17 | 2025 | Ohtuvayre |
| Xeris Pharmaceuticals, INC. | $101.30 | 2023-2025 | Gvoke Hypopen |
| Abbvie INC. | $82.10 | 2023-2025 | |
| Dexcom, INC. | $64.82 | 2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $38.84 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $28.22 | 2023 | Abilify Maintena, Rexulti |
| Teva Pharmaceuticals USA, INC. | $26.55 | 2023 | Austedo |
| Pfizer INC. | $22.58 | 2023 | |
| Novartis Pharmaceuticals Corporation | $16.76 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $13.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.